News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
338,201 Results
Type
Article (18347)
Company Profile (309)
Press Release (319533)
Multimedia
Podcasts (106)
Webinars (13)
Section
Business (95639)
Career Advice (226)
Deals (16903)
Drug Delivery (57)
Drug Development (57457)
Employer Resources (41)
FDA (6905)
Job Trends (6488)
News (171887)
Policy (12009)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (3)
Academia (1018)
Accelerated approval (32)
Adcomms (14)
Allergies (109)
Alliances (24660)
ALS (177)
Alzheimer's disease (1271)
Antibody-drug conjugate (ADC) (407)
Approvals (7242)
Artificial intelligence (396)
Autoimmune disease (269)
Automation (13)
Bankruptcy (121)
Best Places to Work (5558)
BIOSECURE Act (7)
Biosimilars (157)
Biotechnology (235)
Bladder cancer (139)
Brain cancer (60)
Breast cancer (474)
Cancer (4400)
Cardiovascular disease (327)
Career advice (212)
Career pathing (12)
CAR-T (298)
CDC (9)
Celiac Disease (1)
Cell therapy (786)
Cervical cancer (27)
Clinical research (50758)
Collaboration (1583)
Company closure (4)
Compensation (938)
Complete response letters (57)
COVID-19 (1273)
CRISPR (109)
C-suite (848)
Cystic fibrosis (139)
Data (6256)
Decentralized trials (1)
Denatured (21)
Depression (132)
Dermatology (61)
Diabetes (346)
Diagnostics (2187)
Digital health (20)
Diversity (6)
Diversity, equity & inclusion (10)
Drug discovery (283)
Drug pricing (67)
Drug shortages (6)
Duchenne muscular dystrophy (279)
Earnings (41895)
Editorial (35)
Employer branding (8)
Employer resources (39)
Events (62736)
Executive appointments (755)
FDA (9357)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (17)
Frontotemporal dementia (32)
Funding (1296)
Gene editing (238)
Generative AI (37)
Gene therapy (655)
GLP-1 (695)
Government (1345)
Grass and pollen (3)
Guidances (232)
Healthcare (7818)
HIV (48)
Huntington's disease (52)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (96)
Immunology and inflammation (268)
Immuno-oncology (82)
Indications (141)
Infectious disease (1476)
Inflammatory bowel disease (192)
Inflation Reduction Act (10)
Influenza (74)
Intellectual property (222)
Interviews (26)
IPO (9066)
IRA (22)
Job creations (1231)
Job search strategy (176)
JPM (52)
Kidney cancer (10)
Labor market (36)
Layoffs (374)
Leadership (20)
Legal (1739)
Liver cancer (63)
Longevity (23)
Lung cancer (576)
Lymphoma (345)
Machine learning (38)
Management (11)
Manufacturing (602)
MASH (170)
Medical device (3273)
Medtech (3316)
Mergers & acquisitions (8691)
Metabolic disorders (1030)
mRNA (179)
Multiple sclerosis (145)
NASH (15)
Neurodegenerative disease (347)
Neuropsychiatric disorders (100)
Neuroscience (2525)
Neurotech (1)
NextGen: Class of 2026 (2328)
Non-profit (1001)
Now hiring (39)
Obesity (485)
Opinion (174)
Ovarian cancer (198)
Pain (156)
Pancreatic cancer (239)
Parkinson's disease (305)
Partnered (15)
Patents (436)
Patient recruitment (536)
Peanut (50)
People (31160)
Pharmaceutical (46)
Pharmacy benefit managers (8)
Phase 1 (17546)
Phase 2 (23453)
Phase 3 (15452)
Pipeline (6688)
Policy (122)
Postmarket research (960)
Preclinical (7299)
Press Release (32)
Prostate cancer (210)
Psychedelics (61)
Radiopharmaceuticals (309)
Rare diseases (929)
Real estate (1797)
Recruiting (18)
Regulatory (12358)
Reports (22)
Research institute (1071)
Resumes & cover letters (27)
Rett syndrome (35)
RNA editing (27)
RSV (43)
Schizophrenia (162)
Series A (246)
Series B (170)
Service/supplier (2)
Sickle cell disease (105)
Special edition (21)
Spinal muscular atrophy (137)
Sponsored (20)
Startups (2261)
State (1)
Stomach cancer (6)
Supply chain (49)
Tariffs (28)
The Weekly (83)
Vaccines (567)
Venture capital (94)
Weight loss (274)
Women's health (63)
Worklife (3)
Date
Today (79)
Last 7 days (528)
Last 30 days (2504)
Last 365 days (21070)
2026 (8818)
2025 (21182)
2024 (23703)
2023 (26004)
2022 (31455)
2021 (32378)
2020 (27254)
2019 (19205)
2018 (14144)
2017 (16683)
2016 (14149)
2015 (17048)
2014 (12164)
2013 (8702)
2012 (8919)
2011 (9166)
2010 (8903)
Location
Africa (203)
Alabama (75)
Alaska (2)
Arizona (95)
Arkansas (6)
Asia (22334)
Australia (3849)
California (9715)
Canada (2382)
China (1118)
Colorado (318)
Connecticut (387)
Delaware (324)
Europe (49002)
Florida (1195)
Georgia (285)
Hawaii (2)
Idaho (19)
Illinois (547)
India (51)
Indiana (266)
Iowa (10)
Japan (395)
Kansas (84)
Kentucky (11)
Louisiana (15)
Maine (12)
Maryland (1028)
Massachusetts (7508)
Michigan (142)
Minnesota (315)
Mississippi (3)
Missouri (47)
Montana (19)
Nebraska (6)
Nevada (63)
New Hampshire (22)
New Jersey (2432)
New Mexico (16)
New York (2451)
North Carolina (1081)
North Dakota (7)
Northern California (5019)
Ohio (222)
Oklahoma (13)
Oregon (24)
Pennsylvania (1693)
Puerto Rico (15)
Rhode Island (28)
South America (283)
South Carolina (17)
Southern California (3783)
Tennessee (64)
Texas (1322)
United States (31933)
Utah (155)
Virginia (201)
Washington D.C. (44)
Washington State (744)
West Virginia (1)
Wisconsin (95)
Wyoming (1)
338,201 Results for "pipeline therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bayer to Acquire Perfuse Therapeutics to Complement Ophthalmology Pipeline
May 6, 2026
·
6 min read
Press Releases
Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results
May 11, 2026
·
12 min read
Pipeline
Pharma Pipeline Stalls for First Time in Decades: Citeline
Some disease areas bucked the trend of shrinking pipelines, however, with immune and cardiovascular indications seeing an upward trend in investigational assets.
April 6, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Abeona Therapeutics® Reports First Quarter 2026 Results and Provides Pipeline Update
May 13, 2026
·
11 min read
Press Releases
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
May 12, 2026
·
13 min read
Press Releases
Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress
May 8, 2026
·
11 min read
Press Releases
LTZ Therapeutics Raises $38 Million in Support of Advancing Myeloid Engager Immunotherapy Pipeline
May 6, 2026
·
4 min read
Obesity
Obesity ends oncology’s long reign as top contributor to biopharma pipeline value
In its latest biopharma pipeline report, Deloitte warned that the growing importance of a small pool of potential mega-blockbusters raises the risk of “significant value destruction from a single program failure.”
May 4, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights
May 7, 2026
·
17 min read
Press Releases
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
April 7, 2026
·
13 min read
1 of 33,821
Next
